Viewpoints

 
 
  • Obesity, OA, and the Need for Knee Replacement Dr Deane reviews and discusses a study that looks at the relationship between increasing body mass index and knee replacement among patients with osteoarthritis.
  • Biologics: An Important Piece of Patient Advice Dr Deane reviews and discusses a study finding that the majority of patients receiving a biologic drug for their rheumatic disease did not store it at the correct temperature.
  • How Should We Define Sacroiliitis? Dr Deane reviews a study that evaluated the Assessment of SpondyloArthritis international Society (ASAS) in a cohort of patients with persistent low back pain.
  • Should RA Diagnostic Cut-off Points Be Lowered? Dr Deane reviews the results of a study evaluating different cut-off points for scores to diagnose rheumatoid arthritis with the 2010 ACR/EULAR criteria.
  • Sustaining Remission After RA Therapy Ends Dr Deane discusses results from a randomized trial evaluating maintenance of remission after rapid withdrawal of abatacept and methotrexate--alone or in combination.
  • In Those With Psoriasis, Treat for Arthritis? Dr Deane reviews the results of a study that identified and followed patients with cutaneous psoriasis to determine their risk of developing inflammatory arthritis.
  • Casting a 'NET' to Find New Therapies for Lupus Dr Deane discusses a study that first examined the role of neutrophil extracellular traps in lupus pathophysiology, and then evaluated metformin to reduce disease flares in a proof-of-concept trial.
  • The Link Between Sleep Apnea and Gout Dr Deane discusses a recent study that found an association between incident gout and sleep apnea, providing further evidence for a link between cardiopulmonary physiology and hyperuricemia.
  • Rheumatology Advances to Know From 2015 Dr Kevin Deane looks back at the biggest advances in rheumatology in 2015.
  • Visual Outcomes in Idiopathic Intracranial Hypertension A new study looks at risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.
  • New Guidelines for the Management of Polymyalgia Rheumatica Dr Deane reviews the new European League Against Rheumatism and American College of Rheumatology (EULAR/ACR) management guidelines for polymyalgia rheumatica.
  • Comedication in Spondylitis and Anti-TNF Retention Dr Deane reviews and comments on a study evaluating the potential effect of comedication with conventional DMARDs on retention of anti-TNF agent use in spondylitis.
  • Identifying Patients for Reducing Anti-TNF Therapy Dr Deane reviews a recent study describing the use of clinical and ultrasonographic assessment to identify patients who are potential candidates for reduction of anti-tumor necrosis factor therapy.
  • Cancer Risk Factors in Patients With Scleroderma Dr Deane reviews and comments on a recent study evaluating whether demographics and clinical features, such as autoantibody status, are risk factors for cancer in patients with scleroderma.
  • Whole-Body MRI to Detect Enthesitis Dr Deane discusses a study evaluating whole-body MRI to detect enthesitis in patients with psoriatic arthritis and axial spondyloarthritis.
  • Can Allopurinol Reduce Heart Attack Risk? Dr Deane reviews and comments on a recent study looking at the association between use of allopurinol and risk for myocardial infarction.
  • An Early, Unique Feature of RA? Dr. Kevin Deane reviews and comments on a study evaluating the clinical features of early rheumatoid arthritis.
  • How Early Is 'Early Enough' in the Treatment of RA? Dr Kevin Deane reviews and comments on a study evaluating the relationship between the timing of treatment initiation and 'cure' in patients with rheumatoid arthritis.
  • The Earliest Sign of Arthritis? Dr Deane reviews and comments on a study aiming to identify activities that are first associated with knee pain in patients with osteoarthritis.
  • Cardiovascular Disease: The Risk Across Rheumatic Diseases Dr Deane reviews and comments on the results of a longitudinal cohort study evaluating cardiovascular disease risk among patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.